Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5

Our results indicate that ongoing monitoring of emerging mutations is crucial to assess vaccine efficacy against new SARS-CoV-2 variants to identify those with pandemic potential. If protective efficacy declines, it will be imperative to develop new vaccines tailored to current variants of the virus.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2024-10-08
DOI
https://doi.org/10.3390/vaccines12101152
Citations
2
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5

Boris S. Naroditsky, Alina S. Erokhova, Gintsburg Al, Denis Y. Logunov et al.
2 citations
Vaccines
SARS-CoV-2 and COVID-19 Research
0.78
article

Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5

Boris S. Naroditsky, Alina S. Erokhova, Gintsburg Al, Denis Y. Logunov, Anna V. Kovyrshina, Denis I. Zrelkin, Andrey Anatolevich Nedorubov, Artem Y. Shelkov, D. A. Reshetnikov, Daria M. Savina, Ekaterina G. Samokhvalova, Inna V. Dolzhikova, Amir I. Tukhvatulin, Daria M. Grousova, Ilya D. Zorkov, A. A. Ilyukhina, Vladimir А. Gushchin, Alina S. Dzharullaeva, Olga Popova, Olga V. Zubkova, Fatima M. Izhaeva, Polina P. Goldovskaya, Marina E. Komyakova, Andrey G. Botikov, Tatiana A Ozharovskaya, Andrey E. Siniavin, Dmitrii V. Shcheblyakov, А. С. Семихин
article en
2 citations

Abstract

Our results indicate that ongoing monitoring of emerging mutations is crucial to assess vaccine efficacy against new SARS-CoV-2 variants to identify those with pandemic potential. If protective efficacy declines, it will be imperative to develop new vaccines tailored to current variants of the virus.

VaccinesVol. 12(10)
Sechenov University (RU), Ministry of Health of the Russian Federation (RU)
Good health and well-being
Openalex Percentile: Top 27%
SARS-CoV-2 and COVID-19 Research
0.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.